Transcriptional activation of endothelial cells by TGFβ coincides with acute microvascular plasticity following focal spinal cord ischaemia/ reperfusion injury

ASN Neuro

Volumn 1, Issue 3, 2009, Pages 181-194

  Benton, Richard L ^a   Maddie, Melissa A ^a   Dincman, Toros A ^a   Hagg, Theo ^a   Whittemore, Scott R ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Endothelin; Insulin like growth factor binding protein 3 (IGFBP 3); Interleukin 6 (IL 6); Matrix metalloproteinase 9 (MMP 9); Plasminogen activator inhibitor 1 (PAI 1); Urokinase type plasminogen activator (uPA)

Indexed keywords

GELATINASE B; INTERLEUKIN 6; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; SOMATOMEDIN BINDING PROTEIN 3; TRANSFORMING GROWTH FACTOR BETA; UROKINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL LOSS; CELL SURVIVAL; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MICROARRAY ANALYSIS; MICROVASCULATURE; NONHUMAN; NUCLEOTIDE SEQUENCE; RAT; REPERFUSION INJURY; SPINAL CORD INJURY; SPINAL CORD ISCHEMIA; TRANSCRIPTION INITIATION; UPREGULATION; ANIMAL; BIOSYNTHESIS; COMPARATIVE STUDY; METABOLISM; NERVE CELL PLASTICITY; PATHOLOGY; PHYSIOLOGY; RANDOMIZATION; SPRAGUE DAWLEY RAT;

ANIMALS; ENDOTHELIAL CELLS; FEMALE; MICROVESSELS; NEURONAL PLASTICITY; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; RNA, MESSENGER; SPINAL CORD ISCHEMIA; TRANSCRIPTIONAL ACTIVATION; TRANSFORMING GROWTH FACTOR BETA;

EID: 77953421054     PISSN: None     EISSN: 17590914     Source Type: Journal    
DOI: 10.1042/AN20090008     Document Type: Article

References (101)

1. Abbott NJ, Ronnback L, Hansson E (2006) Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 7:41-53.
2. Allaire E, Hasenstab D, Kenagy RD, Starcher B, Clowes MM, Clowes AW (1998) Prevention of aneurysm development and rupture by local overexpression of plasminogen activator inhibitor-1. Circulation 98:249-255.
3. Amar AP, Levy ML (1999) Pathogenesis and pharmacological strategies for mitigating secondary damage in acute spinal cord injury. Neurosurgery 44:1027-1039.
4. Annes JP, Munger JS, Rifkin DB (2003) Making sense of latent TGFβ activation. J Cell Sci 116:217-224.
5. Assoian RK, Komoriya A, Meyers CA, Miller DM, Sporn MB (1983) Transforming growth factor-β in human platelets. Identification of a major storage site, purification, and characterization. J Biol Chem 258:7155-7160.
6. Benton RL, Woock JP, Gozal E, Hetman M, Whittemore SR (2005) Intraspinal application of endothelin results in focal ischemic injury of spinal gray matter and restricts the differentiation of engrafted neural stem cells. Neurochem Res 30:809-823.
7. Benton RL, Maddie MA, Minnillo DR, Hagg T, Whittemore SR (2008a) Griffonia simplicifolia isolectin B4 identifies a specific subpopulation of angiogenic blood vessels following contusive spinal cord injury in the adult mouse. J Comp Neurol 507:1031-1052.
8. Benton RL, Maddie MA, Worth CA, Mahoney ET, Hagg T, Whittemore SR (2008b) Transcriptomic screening of microvascular endothelial cells implicates novel molecular regulators of vascular dysfunction after spinal cord injury. J Cereb Blood Flow Metab 28:1771-1185.
9. Beschorner R, Schluesener HJ, Nguyen TD, Magdolen V, Luther T, Pedal I, Mattern R, Meyermann R, Schwab JM (2000) Lesion-associated accumulation of uPAR. Neuropathol Appl Neurobiol 26:522-527.
10. Binder LI, Frankfurter A, Rebhun LI (1986) Differential localization of MAP-2 and tau in mammalian neurons in situ. Ann N Y Acad Sci. 466:145-166.
11. Burk J, Burggraf D, Vosko M, Dichgans M, Hamann GF (2008) Protection of cerebral microvasculature after moderate hypothermia following experimental focal cerebral ischemia in mice. Brain Res 1226:248-255.
12. Buss A, Pech K, Kakulas BA, Martin D, Schoenen J, Noth J, Brook GA (2008) TGF-b1 and TGF-b2 expression after traumatic human spinal cord injury. Spinal Cord 46:364-371.
13. Casella GT, Marcillo A, Bunge MB, Wood PM (2002) New vascular tissue rapidly replaces neural parenchyma and vessels destroyed by a contusion injury to the rat spinal cord. Exp Neurol 173:63-76.
14. Casella GT, Bunge MB, Wood PM (2006) Endothelial cell loss is not a major cause of neuronal and glial cell death following contusion injury of the spinal cord. Exp Neurol 202:8-20.
15. Chang KH, Chan-Ling T, McFarland EL, Afzal A, Pan H, Baxter LC, Shaw LC, Caballero S, Sengupta N, Li CS, Sullivan SM, Grant MB (2007) IGF binding protein-3 regulates hematopoietic stem cell and endothelial precursor cell function during vascular development. Proc Natl Acad Sci USA 104:10595-10600.
16. Chen Y, McCarron RM, Ohara Y, Bembry J, Azzam N, Lenz FA, Shohami E, Mechoulam R, Spatz M (2000) Human brain capillary endothelium: 2-arachidonoglycerol (endocannabinoid) interacts with endothelin-1. Circ Res 87:323-327.
17. Corti S, Locatelli F, Papadimitriou D, Donadoni C, Del Bo R, Fortunato F, Strazzer S, Salani S, Bresolin N, Comi GP (2005) Multipotentiality, homing properties, and pyramidal neurogenesis of CNS-derived LeX(ssea-1)+/CXCR4+ stem cells. FASEB J 13:1860-1862.
18. Cubellis MV, Nolli ML, Cassani G, Blasi F (1986) Binding of single-chain prourokinase to the urokinase receptor of human U937 cells. J Biol Chem 261:15819-15822.
19. Cunningham LA, Wetzel M, Rosenberg GA (2005) Multiple roles for MMPs and TIMPs in cerebral ischemia. Glia 50:329-339.
20. Debus E, Weber K, Osborn M (1983) Monoclonal antibodies specific for glial fibrillary acidic (GFA) protein and for each of the neurofilament triplet polypeptides. Differentiation 25:193-203.
21. Dhandapani KM, Brann DW (2003) Transforming growth factor-β: a neuroprotective factor in cerebral ischemia. Cell Biochem Biophys 39:13-22.
22. Dietzmann K, von Bossanyi P, Krause D, Wittig H, Mawrin C, Kirches E (2000) Expression of the plasminogen activator system and the inhibitors PAI-1 and PAI-2 in posttraumatic lesions of the CNS and brain injuries following dramatic circulatory arrests: an immunohistochemical study. Pathol Res Pract 196:15-21.
23. Duijvestijn AM, van Goor H, Klatter F, Majoor GD, van Bussel E, van Breda Vriesman PJ (1992) Antibodies defining rat endothelial cells: RECA-1, a pan-endothelial cell-specific monoclonal antibody. Lab Invest 66:459-466.
24. Edvinsson L (2009) Cerebrovascular endothelin receptor upregulation in cerebral ischemia. Curr Vasc Pharmacol 7:26-33.
25. Ferrari G, Pintucci G, Seghezzi G, Hyman K, Galloway AC, Mignatti P (2006) VEGF, a prosurvival factor, acts in concert with TGF-β1 to induce endothelial cell apoptosis. Proc Natl Acad Sci USA 103:17260-17265.
26. Glas M, Popp B, Angele B, Koedel U, Chahli C, Schmalix WA, Anneser JM, Pfister HW, Lorenzl S (2007) A role for the urokinase-type plasminogen activator system in amyotrophic lateral sclerosis. Exp Neurol 207:350-356.
27. Goodman JH, Bingham Jr WG, Hunt WE (1979) Platelet aggregation in experimental spinal cord injury. Ultrastructural observations. Arch Neurol 36:197-201.
28. Griffiths IR, Burns N, Crawford AR (1978) Early vascular changes in the spinal grey matter following impact injury. Acta Neuropathol 41:33-39.
29. Guler HP, Zapf J, Schmid C, Froesch ER (1989) Insulin-like growth factors I and II in healthy man. Estimations of half-lives and production rates. Acta Endocrinol (Copenh) 121:753-758.
30. Hamann GF, Burggraf D, Martens HK, Liebetrau M, Jager G, Wunderlich N, DeGeorgia M, Krieger DW (2004) Mild to moderate hypothermia prevents microvascular basal lamina antigen loss in experimental focal cerebral ischemia. Stroke 35:764-769.
31. Han HS, Suk K (2005) The function and integrity of the neurovascular unit rests upon the integration of the vascular and inflammatory cell systems. Curr Neurovasc Res 2:409-423.
32. Hansen-Schwartz J, Szok D, Edvinsson L (2002) Expression of ET(A) and ET(B) receptor mRNA in human cerebral arteries. Br J Neurosurg 16:149-153.
33. Hawkins BT, Davis TP (2005) The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev 57:173-185.
34. Heussen C, Dowdle EB (1980) Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal Biochem 102:196-202.
35. Hosomi N, Lucero J, Heo JH, Koziol JA, Copeland BR, del Zoppo GJ (2001) Rapid differential endogenous plasminogen activator expression after acute middle cerebral artery occlusion. Stroke 32:1341-1348.
36. Huang J, Urvashi M, Upadhyay BS, Tamargo RJ (2006) Inflammation in stroke and focal cerebral ischemia. Surg Neurol 66:232-245.
37. Jakovcevski I, Wu J, Karl N, Leshchyns'ka I, Sytnyk V, Chen J, Irintchev A, Schachner M (2007) Glial scar expression of CHL1, the close homolog of the adhesion molecule L1, limits recovery after spinal cord injury. J Neurosci 27:7222-7233.
38. Johnsen SP, Hundborg HH, Sørensen HT, ∅rskov H, Tjønneland A, Overvad K, Jørgensen JOL (2005) Insulin-like growth factor (IGF) I, -II, and IGF binding protein-3 and risk of ischemic stroke. J Clin Endocrinol Metab 90:5937-5941.
39. Khodorova A, Montmayeur JP, Strichartz G (2009) Endothelin receptors and pain. J Pain 10:4-28.
40. Kim KS, Kim MS, Seu YB, Chung HY, Kim JH, Kim JR (2007) Regulation of replicative senescence by insulin-like growth factor-binding protein 3 in human umbilical vein endothelial cells. Aging Cell 6:535-545.
41. Koyanagi I, Tator CH, Lea PJ (1993) Three-dimensional analysis of the vascular system in the rat spinal cord with scanning electron microscopy of vascular corrosion casts. Part 2: Acute spinal cord injury. Neurosurgery 33:285-291.
42. Lindholm D, Castren E, Kiefer R, Zafra F, Thoenen H (1992) Transforming growth factor-β1 in the rat brain: increase after injury and inhibition of astrocyte proliferation. J Cell Biol 117:395-400.
43. Linker RA, Lühder F, Kallen K, Lee D, Engelhardt B, Rose-John S, Gold R (2008) IL-6 transsignalling modulates the early effector phase of EAE and targets the blood-brain barrier. J Neuroimmunol 205:64-72.
44. Loy DN, Crawford CH, Darnall JB, Burke DA, Onifer SM, Whittemore SR (2002) Temporal progression of angiogenesis and basal lamina deposition after contusive spinal cord injury in the adult rat. J Comp Neurol 445:308-324.
45. Martinez-Revelles S, Jiménez-Altayó F, Caracuel L, Pérez-Asensio FJ, Planas AM, Vila E (2008) Endothelial dysfunction in rat mesenteric resistance artery after transient middle cerebral artery occlusion. J Pharmacol Exp Therap 325:363-369.
46. Mautes AE, Weinzierl MR, Donovan F, Noble LJ (2000) Vascular events after spinal cord injury: contribution to secondary pathogenesis. Phys Ther 80:673-687.
47. McTigue DM, Popovich PG, Morgan TE, Stokes BT (2000) Localization of transforming growth factor-β1 and receptor mRNA after experimental spinal cord injury. Exp Neurol 163:220-230.
48. Minor KH, Seeds NW (2008) Plasminogen activator induction facilitates recovery of respiratory function following spinal cord injury. Mol Cell Neurosci 37:143-152.
49. Nakamura M, Houghtling RA, MacArthur L, Bayer BM, Bregman BS (2003) Differences in cytokine gene expression profile between acute and secondary injury in adult rat spinal cord. Exp Neurol 184:313-325.
50. Nelson E, Gertz SD, Rennels ML, Ducker TB, Blaumanis OR (1977) Spinal cord injury. The role of vascular damage in the pathogenesis of central hemorrhagic necrosis. Arch Neurol 34:332-333.
51. Noble LJ, Donovan F, Igarashi T, Goussev S, Werb Z (2002) Matrix metalloproteinases limit functional recovery after spinal cord injury by modulation of early vascular events. J Neurosci 22:7526-7535.
52. O'Brien MF, Lenke LG, Lou J, Bridwell KH, Joyce ME (1994) Astrocyte response and transforming growth factor-β localization in acute spinal cord injury. Spine 19:2321-2329.
53. O'Donnell SL, Frederick TJ, Krady JK, Vannucci SJ, Wood TL (2002) IGF-1 and microglia/macrophage proliferation in the ischemic mouse brain. Glia 38:85-97.
54. O'Neill MJ, Clemens JA (2001) Rodent models of focal cerebral ischemia. Curr Protoc Neurosci 9:9.
55. Ogawa T, Sasatomi K, Hiragata S, Seki S, Nishizawa O, Chermansky CJ, Pflug BR, Nelson JB, Chancellor MB, Yoshimura N (2008) Therapeutic effects of endothelin-A receptor antagonist on bladder overactivity in rats with chronic spinal cord injury. Urology 71:341-345.
56. Oh SH, Kim WY, Kim JH, Younes MN, El-Naggar AK, Myers JN, Kies M, Cohen P, Khuri F, Hong WK, Lee HY (2006) Identification of insulin-like growth factor binding protein-3 as a farnesyl transferase inhibitor SCH66336-induced negative regulator of angiogenesis in head and neck squamous cell carcinoma. Clin Cancer Res 12:653-661.
57. Papassotiropoulos A, Hock C, Nitsch RM (2001) Genetics of interleukin 6: implications for Alzheimer's disease. Neurobiol Aging 22:863-871.
58. Peters CM, Rogers SD, Pomonis JD, Egnaczyk GF, Keyser CP, Schmidt JA, Ghilardi JR, Maggio JE, Mantyh PW (2003) Endothelin receptor expression in the normal and injured spinal cord: potential involvement in injuryinduced ischemia and gliosis. Exp Neurol 180:1-13.
59. Pineau I, LaCroix S (2007) Proinflammatory cytokine synthesis in the injured mouse spinal cord: multiphasic expression pattern and identification of the cell types involved. J Comp Neurol 500:267-285.
60. Polavarapu R, Gongora MC, Yi H, Ranganthan S, Lawrence DA, Strickland D, Yepes M (2007) Tissue-type plasminogen activator-mediated shedding of astrocytic low-density lipoprotein receptor-related protein increases the permeability of the neurovascular unit. Blood 109:3270-3278.
61. Popovich PG, Jones TB (2003) Manipulating neuroinflammatory reactions in the injured spinal cord: back to basics. Trends Pharmacol Sci 24:13-17.
62. Quick AM, Cipolla MJ (2005) Pregnancy-induced up-regulation of aquaporin-4 protein in brain and its role in eclampsia. FASEB J 19:170-175.
63. Rainger GE, Nash GB (2001) Cellular pathology of atherosclerosis: smooth muscle cells prime cocultured endothelial cells for enhanced leukocyte adhesion. Circ Res 88:615-622.
64. Rensink AM, Gellekink H, Otte-Höller I, ten Konkelaar HJ, de Waal RM, Verbeek MM, Kremer B (2002) Expression of the cytokine leukemia inhibitory factor and pro-apoptotic insulin-like growth factor binding protein-3 in Alzheimer's disease. Acta Neuropathol 104:525-533.
65. Rose-John S, Waetzig GH, Scheller J, Grotzinger J, Seegert D (2007) The IL-6/sIL-6R complex as a novel target for therapeutic approaches. Expert Opin Ther Targets 11:613-624.
66. Sato Y, Rifkin DB (1989) Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-b1-like molecule by plasmin during co-culture. J Cell Biol 109:309-315.
67. Sato Y, Tsuboi R, Lyons R, Moses H, Rifkin DB (1990) Characterization of the activation of latent TGF-β by co-cultures of endothelial cells and pericytes or smooth muscle cells: a self-regulating system. J Cell Biol 111:757-763.
68. Schinelli S, Zanassi P, Paolillo M, Wang H, Feliciello A, Gallo V (2001) Stimulation of endothelin B receptors in astrocytes induces cAMP response elementbinding protein phosphorylation and c-fos expression via multiple mitogenactivated protein kinase signaling pathways. J Neurosci 21:8842-8853.
69. Schinelli S (2006) Pharmacology and physiopathology of the brain endothelin system: an overview. Curr Med Chem 13:627-638
70. Schwab S, Spranger M, Krempien S, Hacke W, Bettendorf M (1997) Plasma insulin-like growth factor 1 and IGF binding protein 3 levels in patients with acute cerebral ischemic injury. Stroke 28:1744-1748.
71. Seeds NW, Siconolfi LB, Haffke SP (1997) Neuronal extracellular proteases facilitate cell migration, axonal growth, and pathfinding. Cell Tissue Res 290:367-370.
72. Seeds NW, Basham ME, Haffke SP (1999) Neuronal migration is retarded in mice lacking the tissue plasminogen activator gene. Proc Natl Acad Sci USA 96:14118-14123.
73. Seeds NW, Basham ME, Ferguson JE (2003) Absence of tissue plasminogen activator gene or activity impairs mouse cerebellar motor learning. J Neurosci 23:7368-7375.
74. Semple-Rowland SL, Mahatme A, Popovich PG, Green DA, Hassler Jr G, Stokes BT, Streit WJ (1995) Analysis of TGF-β1 gene expression in contused rat spinal cord using quantitative RT-PCR. J Neurotrauma 12:1003-1014.
75. Sharma HS (2005) Pathophysiology of blood-spinal cord barrier in traumatic injury and repair. Curr Pharm Des 11:1353-1389.
76. Sternberger NH, Sternberger LA (1987) Blood-brain barrier protein recognized by monoclonal antibody. Proc Natl Acad Sci USA 84:8169-8173.
77. Streit WJ, Semple-Rowland SL, Hurley SD, Miller RC, Popovich PG, Stokes BT (1998) Cytokine mRNA profiles in contused spinal cord and axotomized facial nucleus suggest a beneficial role for inflammation and gliosis. Exp Neurol 152:74-87.
78. Tarkowski E, Rosengren L, Blomstrand C, Wikkelsö C, Jensen C, Ekholm S, Tarkowski A (1995) Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke. Stroke 26:1393-1398.
79. ten Dijke P, Arthur HM (2007) Extracellular control of TGFβ signalling in vascular development and disease. Nat Rev Mol Cell Biol 8:857-869.
80. Tinsley JH, Hunter FA, Childs EW (2009) PKC and MLCK-dependent, cytokineinduced rat coronary endothelial dysfunction. J Surg Res 152:76-83.
81. Tkachuk V, Stepanova V, Little PJ, Bobik A (1996) Regulation and role of urokinase plasminogen activator in vascular remodelling. Clin Exp Pharmacol Physiol 23:759-765.
82. Tsaur ML, Wan YC, Lai FP, Cheng HF (1997) Expression of B-type endothelin receptor gene during neural development. FEBS Lett 417:208-212.
83. Tsirka SE, Rogove AD, Bugge TH, Degen JL, Strickland S (1997) An extracellular proteolytic cascade promotes neuronal degeneration in the mouse hippocampus. J Neurosci 17:543-552.
84. Tuschick S, Kirischuk S, Kirchhoff F, Liefeldt L, Paul M, Verkhratsky A, Kettenmann H (1997) Bergmann glial cells in situ express endothelinB receptors linked to cytoplasmic calcium signals. Cell Calcium 21:409-419.
85. Uesugi M, Kasuya Y, Hayashi K, Goto K (1998) SB209670, a potent endothelin receptor antagonist, prevents or delays axonal degeneration after spinal cord injury. Brain Res 786:235-239.
86. Wang S, Lim G, Zeng Q, Sung B, Ai Y, Guo G, Yang L, Mao J (2004) Expression of central glucocorticoid receptors after peripheral nerve injury contributes to neuropathic pain behaviors in rats. J Neurosci 24:8595-8605.
87. Wang TD, Wang YH, Huang TS, Su TC, Pan SL, Chen SY (2007) Circulating levels of markers of inflammation and endothelial activation are increased in men with chronic spinal cord injury. J Formos Med Assoc 106:919-928.
88. Wang X, Yue TL, Young PR, Barone FC, Feuerstein GZ (1995) Expression of interleukin-6, c-fos, and zif268 mRNAs in rat ischemic cortex. J Cereb Blood Flow Metab 15:166-171.
89. Wang X, Chen W, Liu W, Wu J, Shao Y, Zhang X (2009) The role of thrombospondin-1 and transforming growth factor-β after spinal cord injury in the rat. J Clin Neurosci 16:818-821.
90. Ward NL, LaManna JC (2004) The neurovascular unit and its growth factors: coordinated response in the vascular and nervous systems. Neurol Res 26:870-883.
91. 2-induced cell death. Am J Respir Cell Mol Biol 29:513-522.
92. Whetstone WD, Hsu JY, Eisenberg M, Werb Z, Noble-Haeusslein LJ (2003) Blood-spinal cord barrier after spinal cord injury: relation to revascularization and wound healing. J Neurosci Res 74:227-239.
93. Yamada H, Kurokawa K (1998) Histochemical studies on endothelin and the endothelin-A receptor in the hypothalamus. J Cardiovasc Pharmacol 31(Suppl 1):S215-S218.
94. Yamada PM, Lee KW (2009) Perspectives in mammalian IGFBP-3 biology: local vs. systemic action. Am J Physiol Cell Physiol 296:C954-C976.
95. Yao J, Harvath L, Gilbert DL, Colton CA (1990) Chemotaxis by a CNS macrophage, the microglia. J Neurosci Res 27:36-42.
96. Ye P, Price W, Kassiotis G, Kollias G, D'Ercole AJ (2003) Tumor necrosis factora regulation of insulin-like growth factor-I, type 1 IGF receptor, and IGF binding protein expression in cerebellum of transgenic mice. J Neurosci Res 71:721-731.
97. Yin KJ, Cirrito JR, Yan P, Hu X, Xiao Q, Pan X, Bateman R, Song H, Hsu FF, Turk J, Xu J, Hsu CY, Mills JC, Holtzman DM, Lee JM (2006) Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid-β peptide catabolism. J Neurosci 26:10939-10948.
98. Yu JC, Pickard JD, Davenport AP (1995) Endothelin ETA receptor expression in human cerebrovascular smooth muscle cells. Br J Pharmacol 116:2441-2446.
99. Zhang Y, Pothakos K, Tsirka SA (2005) Extracellular proteases: biological and behavioral roles in the mammalian central nervous system. Curr Top Dev Biol 66:161-188.
100. Zimmermann EM, Li L, Hoyt EC, Pucilowska JB, Lichtman S, Lund PK (2000) Cell-specific localization of insulin-like growth factor binding protein mRNAs in rat liver. Am J Physiol Gastrointest Liver Physiol 278:G447-G457.
101. Zlokovic BV (2008) The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57:178-201.